All Type of News
VGX International discloses cGMP based expertise
VGX International Inc., a Korean affiliate of the US-based VGX Pharmaceuticals, held its VGX2007 workshop at JW Marriott Hotel in Seoul on July 12 to enhance cooperation and exchange opinions on cGMP based new drug pr...
Parties yet to narrow differences over shady dealsRepresentatives from industry and academia had a meeting to discuss ways of eliminating irregular business practices in the domestic pharmaceutical industry on July 9 but failed...
|
MOL to enforce national qualification for medical device technicians.
Taking effect from the next year all technicians in the medical, industrial and medical electronic industries shall be qualified under the national licence issued by the Ministry of Labor (MOL).
The MOL said on Jul...
7 local hospitals trying phase III clinical studies for Sutent.
Pfizer planned a phase III clinical study of Sutent (sunitinib malate) for the metastatic colorectal cancer (mCRC) patients to evaluate its safety and efficacy in combination with the conventional chemotherapy.
Ear...
Pharmacists worry of less health insurance coverage in minor disease
With the government's plan to lower health insurance benefits for treatment of minor ailments while increasing coverage for advanced illnesses from next month, there are growing concerns amongst pharmacists that pharm...
Dongkoo to introduce UK Bioplax's dental products
Dongkoo Pharm Co. said on July 5 that it signed an exclusive agreement with UK based Bioplax Ind. to distribute Bioplax's four dental medicines containing sodium hyaluronate for treatment of stomatitis.
Dongkoo is ...
New one-a-day low dose of Cialis launching soon.
Lilly Korea said that a new dosage form of Cialis one-a-day (2.5mg and 5mg) was approved in European Commission. Now, the patients with erectile dysfunction could get normal sexual life freely by taking a new Cialis p...
HS Biopharm acquires Kyungnam Pharm
HS Biopharm, local human placenta manufacturer, said on July 9 that it acquired 100 percent stake of Kyungnam Pharm owned by Green Cross Corporation (GCC) and GCC holding.
An official of HS Biopharm said that for t...
Leading wholesalers develop differentiated incentive system
Major drug wholesalers plan to adopt the so-called differentiated incentive system for their salespersons as part of efforts to decrease the sales portion of drugs produced by 11 multinational drug manufacturers who h...
US vaccine maker to establish research and production facilities
VGX Pharmaceutical Inc., a U.S pharmaceutical company, will invest $200 million in building its Asian regional headquarters in Korea, according to the Ministry of Health and Welfare on July 9.
VGX is a leading biop...
